Rockford, IL, United States of America

Vineet N Kewalramani

This inventor holds 2 USPTO granted patents. Top assignee: New York University. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vineet N Kewalramani. Retrieved from https://idiyas.com/inventor/vineet-n-kewalramani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Vineet N Kewalramani

Introduction

Vineet N Kewalramani is a notable inventor based in Rockford, IL (US). He has made significant contributions to the field of biomedical research, particularly in the study of retroviral entry into cells.

Latest Patents

Kewalramani holds 2 patents that focus on G-coupled receptors associated with retroviral entry into cells. His latest patents include innovative agents known as Bonzo and BOB, which promote HIV/SIV translocation. These inventions provide essential amino acid and DNA sequences of the receptor protein Bonzo from various primate species. The patents also disclose methods for identifying additional translocation promoting agents and their diagnostic and therapeutic applications. Furthermore, they outline methods to modulate the expression and function of Bonzo/STRL33, which can be utilized to treat inflammation or enhance immune responses.

Career Highlights

Kewalramani is affiliated with New York University, where he continues to advance his research in the field. His work has garnered attention for its potential impact on therapeutic strategies against retroviral infections.

Collaborations

He has collaborated with esteemed colleagues such as Dan R Littman and Hongkui Deng, contributing to a rich environment of innovation and discovery.

Conclusion

Vineet N Kewalramani's work exemplifies the intersection of innovation and biomedical research, showcasing his commitment to advancing our understanding of retroviral mechanisms and potential treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…